Financial Modeling Prep·2026-03-12 15:00Core Insights - Inter & Co, Inc. (NASDAQ:INTR) operates in the financial services sector, facing competition from various financial service providers such as Alvotech, ProKidney Corp., Global Business Travel Group, Inc., and Commercial International Bank (Egypt) S.A.E. [1] Financial Performance - Inter & Co, Inc. has a Return on Invested Capital (ROIC) of 1.42% and a Weighted Average Cost of Capital (WACC) of 10.00%, resulting in a ROIC to WACC ratio of 0.14, indicating potential inefficiencies in capital utilization [2][6] - Alvotech (ALVO) has a ROIC of 3.74% and a WACC of 7.98%, leading to a ROIC to WACC ratio of 0.47, suggesting more effective capital utilization compared to INTR [3] - Global Business Travel Group, Inc. (GBTG) shows a ROIC of 3.59% and a WACC of 8.57%, with a ROIC to WACC ratio of 0.42, indicating better capital efficiency than INTR [3] - ProKidney Corp. (PROK) has a negative ROIC of -52.92% and a WACC of 12.14%, resulting in a ROIC to WACC ratio of -4.36, highlighting significant challenges in capital utilization [4] - Commercial International Bank (Egypt) S.A.E (CIBEY) stands out with a ROIC of 28.66% and a WACC of 22.91%, achieving a ROIC to WACC ratio of 1.25, indicating efficient capital utilization and potential for higher shareholder value [5][6]